Drug recall · September 2, 2020
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection recall
Why: Cross Contamination with other products: trace amounts of lidocaine
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05
- Lots / codes
Lot #: 6121853, Exp 05/2021; 6122207, Exp 06/2021
- Quantity
- 25,100 bottles
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- U.S.A. Nationwide
- Initiated
- July 22, 2020 · Voluntary: Firm initiated
- Classified
- August 21, 2020
- Reported
- September 2, 2020
- Ended
- September 12, 2022
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dexmedetomidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.